Novasign at a Glance
We love to model processes!
Accelerating the development of bioprocesses ensures reduced development timelines and a better process understanding
New drugs can take 10-14 years and cost on average $1.8 bn to develop before entering the market. Consecutively, the net effect is that the price per dose easily exceeds $10,000.
The pressure downstream on the patients, the healthcare systems and insurance is intense with an aging and growing population.
This is why we need novel biopharmaceuticals earlier, and therefore cheaper, on the market.
Drug life cycle
We believe that every day & dollar saved, and every data insight gained, benefits the society and business.
We achieve a reduced time to market by an accelerated bioprocess development.
In this three-stage model of discovery, process development and commercialization we illustrate the under-investment in process development and the poor knowledge and generated understanding of bioprocesses.
Almost all resources are invested in drug discovery and commercialization. We believe that this resource 'gap' at the process side has to be tackled, to enable early and affordable bioprocess improvements that yield disproportionate rewards.
Advantages of increased process understanding
Faster development timelines
A higher return of investment
Fewer required experiments, i.e., saving on experimental time, energy and materials
Deeper process understanding of how critical process parameters impact the products' critical quality attributes in a time-resolved manner
Higher transparency for regulatory bodies
Straightforward process know-how transfer between different products
We are meeting your needs if you
are under pressure to reduce development timelines for new drugs, biosimilars and other biologically derived molecules (in red and white biotech)
have growing needs for tools to better understand processes with the goal of achieving higher yields or a more stable process
are seeking to fulfill the FDA’s QbD and PAT guidelines in a timely and cost-effective manner
Bioprocess development contract research with powerful equipment due to the proximity to BOKU core facilities (cultivations and purification from HT Screening until Pilot Plant). Also full analytical method spectrum (including SPR, MS...). Combining process and modeling expertise.
Time-resolved hybrid models of your processes
Including Digital Twin, model-based and intensified DoE functionalities to speed up your bioprocess developemnt
Monitor your own modeling progress anytime and anywhere by using the Novasign Portal